Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E9UH
|
|||
| Drug Name |
RP1
|
|||
| Synonyms |
Dimethyl cyclohex-4-ene-1,2-dicarboxylate; RP 1 (ester); Dimethyl 4-cyclohexene-1,2-dicarboxylate; RP 1; 7500-55-2; 4-CYCLOHEXENE-1,2-DICARBOXYLIC ACID, DIMETHYL ESTER; NSC 401683; BRN 1876401; AI3-03408; DVVAGRMJGUQHLI-UHFFFAOYSA-N; 4-Cyclohexene-1,2-dicarboxylic acid, 1,2-dimethyl ester; dimethyl cyclohex-4-ene-1,2-dicarboxylate; 1,2-dimethyl cyclohex-4-ene-1,2-dicarboxylate; RP-1[ester]; ACMC-209eby; ACMC-209kd2; cis-4-Cyclohexene-1,2-dicarboxylic Acid Dimethyl Ester; AC1Q43VK; NCIOpen2_000700; SCHEMBL418070; AC1L2N81; RP-1; CTK5E0893; 4-Cyclohexene-1, dimethyl ester
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1/2 | [1] | |
| Company |
Replimmune Woburn, MA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H12N5O5PS
|
|||
| Canonical SMILES |
C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=S)(O1)O
|
|||
| InChI |
1S/C10H12N5O5PS/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(19-10)1-18-21(17,22)20-7/h2-4,6-7,10,16H,1H2,(H,17,22)(H2,11,12,13)/t4-,6-,7-,10-,21?/m1/s1
|
|||
| InChIKey |
SMPNJFHAPJOHPP-JOILOJCLSA-N
|
|||
| CAS Number |
CAS 23645-17-2
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:84615
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.